Fairmount Healthcare Fund II L.P.'s Net Worth
$9.53 Million
Who is Fairmount Healthcare Fund II L.P.?
Fairmount Healthcare Fund II L.P. has an estimated net worth of $9.53 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, and Spyre Therapeutics, Inc..
SEC CIK
Fairmount Healthcare Fund II L.P.'s CIK is 0001769651
Past Insider Trading and Trends
2020 was Fairmount Healthcare Fund II L.P.'s most active year for acquiring shares with 6 total transactions. Fairmount Healthcare Fund II L.P.'s most active month to acquire stocks was the month of September. 2023 was Fairmount Healthcare Fund II L.P.'s most active year for disposing of shares, totalling 1 transactions. Fairmount Healthcare Fund II L.P.'s most active month to dispose stocks was the month of December. 2023 saw Fairmount Healthcare Fund II L.P. paying a total of $50,000,329.24 for 3,500,610 shares, this is the most they've acquired in one year. In 2024 Fairmount Healthcare Fund II L.P. cashed out on 892,529 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apogee Therapeutics, Inc. (APGE) Snapshot price: $36.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.05M |
Mar 28
| |||
Form 4
| -88.53% | -790.20K |
—
|
—
| 102.33K |
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 2.94M |
$17.00 | $49,999,992.00 | 2.94M |
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +961.81% | 3.64M |
—
|
—
| 4.02M |
Apr 25
| |||
Form 4
| -76.36% | -2.62M |
—
|
—
| 812.08K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
∞
| 3.44M |
—
|
—
| 3.44M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $17.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 1.85M |
Mar 28
| |||
Form 4
| +34.92% | 476.19K |
$21.00 | $9,999,990.00 | 1.84M |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| +45.35% | 425.53K |
$23.50 | $9,999,978.50 | 1.36M |
Aug 17
| |||
Form 4
| +3,109.50% | 909K |
$11.00 | $9,999,000.00 | 938.23K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 526.39K |
—
|
—
| 526.39K |
Oct 27
| |||
| No matching records found | |||||||||